We report a patient who received a single, left lung transplantation for idiopathic pulmonary fibrosis. The effect of the graft on pulmonary improvement was only temporary, because the patient developed obliterative bronchiolitis (OB), resulting in complete destruction of the graft. The patient, however, remains alive 6 years after OB was diagnosed, apparently as a consequence of native lung improvement with triple-immunosuppressive medicine. This case is of interest for several reasons: first, it shows that pulmonary fibrosis may respond to intensive immunosuppressive therapy; second, it demonstrates that ventilation scintigraphy is useful in addition to pulmonary function tests in estimating the actual function of the graft after single l...
Abstract Background Survival after lung transplantation (LTx) is often limited by bronchiolitis obli...
SummaryBackgroundSingle lung transplant recipients with idiopathic pulmonary fibrosis provide an opp...
Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal fibrosing lung disease ...
We report a patient who received a single, left lung transplantation for idiopathic pulmonary fibros...
AbstractChronic obstructive pulmonary disease (COPD) is now the most common indication for single lu...
Spirometry is regarded as the primary tool for the evaluation of lung function in lung transplant (L...
Background: A decrease in forced expiratory volume in 1 second (FEV1) as a diagnostic criterion for ...
Background: Pulmonary fibrosis is a heterogenous group of diseases and usually an irreversible cond...
AbstractObjective: To evaluate the changes in lung function in the first year after single lung tran...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
BACKGROUND: Lung transplant (LTx) recipients have low long-term survival and a high incidence of bro...
Background: Primary graft dysfunction (PGD) is an early complication of lung transplantation associ...
Background - Lung transplant recipients have reduced long-term survival compared with other solid or...
Lung transplantation (uni- or bilateral) is an accepted treatment option for patients with end-stage...
BACKGROUND Development of bronchiolitis obliterans syndrome (BOS) is a great limitation for patient ...
Abstract Background Survival after lung transplantation (LTx) is often limited by bronchiolitis obli...
SummaryBackgroundSingle lung transplant recipients with idiopathic pulmonary fibrosis provide an opp...
Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal fibrosing lung disease ...
We report a patient who received a single, left lung transplantation for idiopathic pulmonary fibros...
AbstractChronic obstructive pulmonary disease (COPD) is now the most common indication for single lu...
Spirometry is regarded as the primary tool for the evaluation of lung function in lung transplant (L...
Background: A decrease in forced expiratory volume in 1 second (FEV1) as a diagnostic criterion for ...
Background: Pulmonary fibrosis is a heterogenous group of diseases and usually an irreversible cond...
AbstractObjective: To evaluate the changes in lung function in the first year after single lung tran...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
BACKGROUND: Lung transplant (LTx) recipients have low long-term survival and a high incidence of bro...
Background: Primary graft dysfunction (PGD) is an early complication of lung transplantation associ...
Background - Lung transplant recipients have reduced long-term survival compared with other solid or...
Lung transplantation (uni- or bilateral) is an accepted treatment option for patients with end-stage...
BACKGROUND Development of bronchiolitis obliterans syndrome (BOS) is a great limitation for patient ...
Abstract Background Survival after lung transplantation (LTx) is often limited by bronchiolitis obli...
SummaryBackgroundSingle lung transplant recipients with idiopathic pulmonary fibrosis provide an opp...
Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal fibrosing lung disease ...